Health Discovery(HDVY)
$0.00-0.00 (-99.50%)
HDVY
Health Discovery financials statements
$0.00
At close:-0.00 (-99.50%)
Health Discovery (HDVY) Ratios
30 Followers
Health Discovery Ratios
HDVY's free cash flow for Q3 2021 was $-435.00K. For the 2021 fiscal year, HDVY's free cash flow was increased by $0.00 and operating cash flow was $-435.00K. See a summary of the company’s cash flow.
| Ratios | Dec 20 | Dec 19 | Dec 18 | Dec 17 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 1.67 | 0.83 | 0.00 | 0.08 |
| Quick Ratio | 1.67 | 0.83 | 0.00 | 0.08 |
| Cash Ratio | 1.65 | 0.82 | 0.00 | 0.08 |
| Solvency Ratio | -1.36 | 0.62 | -0.46 | -0.82 |
| Operating Cash Flow Ratio | -2.48 | 0.79 | -0.24 | -0.57 |
| Short-Term Operating Cash Flow Coverage | -6.50 | 11.01 | -0.68 | 0.00 |
| Net Current Asset Value | $ 375.00K | $ -470.51K | $ -1.15M | $ -700.92K |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.23 | 0.09 | 2.66 | 0.38 |
| Debt-to-Equity Ratio | 0.57 | -0.43 | -0.41 | -0.61 |
| Debt-to-Capital Ratio | 0.36 | -0.74 | -0.69 | -1.59 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | -1.59 |
| Financial Leverage Ratio | 2.49 | -4.91 | -0.15 | -1.61 |
| Debt Service Coverage Ratio | -3.37 | 0.82 | -1.17 | -493.29 |
| Interest Coverage Ratio | -174.20 | 43.19 | -29.77 | -710.41 |
| Debt to Market Cap | 0.01 | 0.01 | 0.25 | 0.11 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.94 | -1.20 | -0.80 | -0.22 |
| Profitability Margins | ||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -74900.00% | 105.22% | -1737.29% | -1912.30% |
| EBITDA Margin | -74900.00% | 115.28% | -1144.25% | -1327.85% |
| Operating Profit Margin | -174200.00% | 105.22% | -1737.29% | -1912.30% |
| Pretax Profit Margin | -75900.00% | 102.76% | -1795.65% | -1944.09% |
| Net Profit Margin | -75900.00% | 102.78% | -1795.65% | -1944.09% |
| Continuous Operations Profit Margin | -75900.00% | 0.00% | -1795.65% | -1944.09% |
| Net Income Per EBT | 100.00% | 100.02% | 100.00% | 100.00% |
| EBT Per EBIT | 43.57% | 97.66% | 103.36% | 101.66% |
| Return on Assets (ROA) | -81.44% | 67.50% | -520.00% | -190.32% |
| Return on Equity (ROE) | -202.40% | -331.77% | 80.05% | 306.32% |
| Return on Capital Employed (ROCE) | -464.53% | -339.64% | 77.45% | 932.19% |
| Return on Invested Capital (ROIC) | -296.76% | -9.74% | 131.18% | 932.19% |
| Return on Tangible Assets | -81.44% | 67.50% | -1187274.63% | -2006.95% |
| Earnings Yield | -4.22% | 9.56% | -47.99% | -53.60% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.66 | 0.29 | 0.10 |
| Working Capital Turnover Ratio | -0.02 | -1.88 | -0.05 | -0.15 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.00 | 0.01 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | 0.01 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -6.50 | 11.01 | -0.68 | -1.79 |
| Operating Cash Flow to Sales Ratio | -1379.00 | 1.45 | -6.22 | -6.99 |
| Free Cash Flow Yield | -7.67% | 13.49% | -16.62% | -19.26% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -23.68 | 10.46 | -2.08 | -1.87 |
| Price-to-Sales (P/S) Ratio | 17972.98 | 10.75 | 37.42 | 36.27 |
| Price-to-Book (P/B) Ratio | 47.93 | -34.69 | -1.67 | -5.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.03 | 7.41 | -6.02 | -5.19 |
| Price-to-Operating Cash Flow Ratio | -13.03 | 7.41 | -6.02 | -5.19 |
| Price-to-Earnings Growth (PEG) Ratio | 0.16 | -0.04 | 0.22 | 0.03 |
| Enterprise Value Multiple | -23.05 | 8.13 | -4.07 | -2.95 |
| Enterprise Value | 17.27M | 14.23M | 2.06M | 1.76M |
| EV to EBITDA | -23.05 | 8.13 | -4.07 | -2.95 |
| EV to Sales | 17267.98 | 9.37 | 46.60 | 39.19 |
| EV to Free Cash Flow | -12.52 | 6.46 | -7.49 | -5.61 |
| EV to Operating Cash Flow | -12.52 | 6.46 | -7.49 | -5.61 |
| Tangible Book Value Per Share | 0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | 0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 1.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | 0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 0.98 | 1.03 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1743.00 | 0.85 | 12.44 | 14.28 |
| Stock-Based Compensation to Revenue | 268.00 | 0.34 | 1.96 | 1.47 |
| Income Quality | 1.82 | 1.41 | 0.35 | 0.36 |
Currency in USD

